Home > Boards > US Listed > Biotechs > Aclaris Therapeutics, Inc. (ACRS)

ACRS cheapest and most attractive Biotech to hold

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
ADVFN_bioking Member Profile
 
Followed By 21
Posts 630
Boards Moderated 0
Alias Born 05/15/17
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 12/7/2021 7:03:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/3/2021 4:53:32 PM
Aclaris Therapeutics Announces Publication of Preclinical Research of Zunsemetinib in Pancreatic Cancer in Science Translational Medicine GlobeNewswire Inc. - 12/3/2021 7:00:00 AM
Aclaris Therapeutics to Host Virtual R&D Day on December 7, 2021 GlobeNewswire Inc. - 11/18/2021 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/3/2021 4:19:41 PM
Aclaris Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire Inc. - 11/3/2021 7:00:00 AM
Aclaris Therapeutics EPS misses by $0.07, misses on revenue Seeking Alpha - 11/2/2021 7:40:31 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/2/2021 7:33:12 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/2/2021 7:17:46 AM
Aclaris Therapeutics Reports Third Quarter 2021 Financial Results and Provides a Corporate Update GlobeNewswire Inc. - 11/2/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/2/2021 5:39:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/27/2021 4:12:43 PM
Aclaris Therapeutics Announces Proposed Settlement and Settlement Hearing of Stockholder Derivative Action GlobeNewswire Inc. - 8/27/2021 4:01:00 PM
Aclaris Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire Inc. - 8/26/2021 4:01:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/5/2021 7:32:36 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2021 7:16:31 AM
Aclaris Therapeutics Reports Second Quarter 2021 Financial Results and Provides a Corporate Update GlobeNewswire Inc. - 8/5/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/26/2021 4:02:07 PM
Aclaris price target raised at Jefferies citing ‘significant stock moving event’ Seeking Alpha - 7/23/2021 3:37:32 PM
Aclaris Therapeutics to Participate in the William Blair Biotech Focus Conference 2021 GlobeNewswire Inc. - 7/8/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 6:04:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/11/2021 4:02:30 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/10/2021 4:26:36 PM
Aclaris Therapeutics secures $125M capital via equity raise Seeking Alpha - 6/10/2021 12:29:04 AM
Aclaris Announces Pricing of Public Offering of Common Stock GlobeNewswire Inc. - 6/9/2021 7:55:00 PM
ADVFN_bioking   Tuesday, 10/08/19 11:48:13 AM
Re: None
Post # of 313 
ACRS cheapest and most attractive Biotech to hold during Q4

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences